Chloromethane

Chloromethane

SCHEMBL248726

CCl.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.80
TDP1 Q9NUW8 1/20 0.80
ESR1 P03372 4/20 0.57
ESR2 Q92731 4/20 0.57
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 3/20 0.38
DRD1 P21728 2/20 0.38
LMNA P02545 2/20 0.37
ALOX12 P18054 1/20 0.37
ACHE P22303 1/20 0.37
KCNN4 O15554 3/20 0.35
NPSR1 Q6W5P4 1/20 0.34
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloromethane SCHEMBL6903208 0.97 CYP3A4 (0.75) CYP3A4TDP1ESR1ESR2KDM4E
Carbon Tetrachloride SCHEMBL313349 0.90 CYP3A4 (0.75) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL81285 0.90 TDP1 (0.86) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL3181354 0.90 TDP1 (0.86) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL1951204 0.90 TDP1 (0.86) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL9420677 0.90 TDP1 (0.86) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL561726 0.90 TDP1 (0.86) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL5028587 0.89 TDP1 (1.00) CYP3A4TDP1ESR1ESR2KDM4E
Benzene SCHEMBL6890099 0.89 TDP1 (1.00) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL101 0.89 TDP1 (1.00) CYP3A4TDP1ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111378456-B Negative liquid crystal compound containing terminal alkenyl and synthetic method thereof 江苏和成新材料有限公司 2023-03-31 CN claimed
CN-111378456-A Negative liquid crystal compound containing terminal alkenyl and synthetic method thereof 江苏和成新材料有限公司 2020-07-07 CN claimed
CN-103086848-B Dicyclohexylalkyl ether terminal olefines liquid crystal compound and preparation method thereof YANTAI DERUN LIQUID CRYSTAL MATERIALS CO LTD 2014-09-03 CN claimed
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2013-06-27 US claimed
EP-2588441-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR Actavis Group Ptc Ehf (IS) 2013-05-08 EP claimed
CN-103086848-A Dicyclohexylalkyl ether terminal olefines liquid crystal compound and preparation method thereof YANTAI DERUN LIQUID CRYSTAL MATERIALS CO LTD 2013-05-08 CN claimed
WO-2012001531-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2012-01-05 WO claimed
US-6432616-B1 Water soluble polymer and photoresist composition containing the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2002-08-13 US claimed
CN-114702184-B High-salt high-organic matter wastewater treatment device and method 西安瑞联新材料股份有限公司 2023-09-29 CN disclosed
CN-116422376-A Platinum-ionic liquid complex catalyst for catalyzing hydrochlorination of acetylene as well as preparation method and application thereof 石河子大学 2023-07-14 CN disclosed
CN-111378456-B Negative liquid crystal compound containing terminal alkenyl and synthetic method thereof 江苏和成新材料有限公司 2023-03-31 CN disclosed
CN-114702184-A High-salt high-organic-matter wastewater treatment device and method 西安瑞联新材料股份有限公司 2022-07-05 CN disclosed
EP-3275924-B1 TWO-PACK TYPE EPOXY RESIN COMPOSITION FOR FIBER-REINFORCED COMPOSITE MATERIAL, AND FIBER-REINFORCED COMPOSITE MATERIAL TORAY INDUSTRIES (JP) 2021-11-24 EP disclosed
US-10717831-B2 Two-component type epoxy resin composition for fiber-reinforced composite material, and fiber-reinforced composite material TORAY INDUSRIES, INC. (JP) 2020-07-21 US disclosed
US-4546106-A ANTIARTHRITIC AGENTS MERCK & CO., INC. (US) 1985-10-08 US disclosed
US-4355034-A Ethenyl derivatives of mercaptoalkylpyridines as anti-inflammatory agents MERCK & CO., INC. (US) 1982-10-19 US disclosed
US-4217352-A ANTIARTHRITIC AGENT MERCK & CO., INC. (US) 1980-08-12 US disclosed
US-4144342-A ANTIARTHRITIC AND ANTIINFLAMMATORY AGENTS MERCK & CO., INC. (US) 1979-03-13 US disclosed
US-4061759-A ANTIINFLAMMATORY, ARTHRITIS MERCK & CO., INC. (US) 1977-12-06 US disclosed
US-4053606-A ANTIINFLAMMATORY AND ANTIARTHRITIC AGENTS MERCK & CO., INC. (US) 1977-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR THPO, P2RY4, TBXA2R CYP3A4 28/4885TDP1 1304/4885ESR1 4604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.